These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 601748)

  • 41. The effect of heparin on factor XIa and plasmin.
    Rosenberg RD
    Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
    [No Abstract]   [Full Text] [Related]  

  • 42. [Investigations on the mechanism of the antithrombin effect of heparin].
    MARKWARDT F; WALSMANN P
    Hoppe Seylers Z Physiol Chem; 1959; 317():64-77. PubMed ID: 14421334
    [No Abstract]   [Full Text] [Related]  

  • 43. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.
    Olson ST; Björk I; Shore JD
    Methods Enzymol; 1993; 222():525-59. PubMed ID: 8412815
    [No Abstract]   [Full Text] [Related]  

  • 44. Evidence of a catalytic role of heparin in anticoagulation reactions.
    Gitel SN
    Adv Exp Med Biol; 1975; 52():243-7. PubMed ID: 1124699
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.
    Hijikata-Okunomiya A; Okamoto S; Wanaka K
    Thromb Res; 1990 Sep; 59(6):967-77. PubMed ID: 2264021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
    Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI
    Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate.
    Griffith MJ
    Thromb Res; 1982 Feb; 25(3):245-53. PubMed ID: 7064134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of action of heparin through thrombin on blood coagulation.
    Machovich R
    Biochim Biophys Acta; 1975 Nov; 412(1):13-7. PubMed ID: 1191673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interaction of heparin with thrombin and antithrombin.
    Rosenberg RD; Oosta GM; Jordan RE; Gardner WT
    Biochem Biophys Res Commun; 1980 Oct; 96(3):1200-8. PubMed ID: 7437065
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN; Girardot C; Lecoffre C; Lunven C
    Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of heparin adsorbed on Sepharose-lysine on the inactivation of thrombin by anti-thrombin III [proceedings].
    Hatton MW; Kaur H; Regoeczi E
    Biochem Soc Trans; 1977; 5(5):1443-6. PubMed ID: 923954
    [No Abstract]   [Full Text] [Related]  

  • 54. The sensitivity of human and bovine thrombin to heparin in plasma.
    Denson KW
    Thromb Res; 1981 Aug; 23(3):207-13. PubMed ID: 7302926
    [No Abstract]   [Full Text] [Related]  

  • 55. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation.
    Ruzicka K; Wojta J; Artemiou O; Birsan T; Quehenberger P; Kapiotis S; Hofbauer R; Speiser W
    Life Sci; 1998; 63(17):1493-503. PubMed ID: 9808060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation-fibrinolytic mechanism and the action of heparin.
    Rosenberg RD
    Adv Exp Med Biol; 1975; 52():217-37. PubMed ID: 235831
    [No Abstract]   [Full Text] [Related]  

  • 59. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
    Callas DD; Fareed J
    Thromb Res; 1995 Jun; 78(5):457-60. PubMed ID: 7544924
    [No Abstract]   [Full Text] [Related]  

  • 60. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
    Odegård OR; Lie M
    Thromb Res; 1978 Apr; 12(4):697-700. PubMed ID: 663903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.